| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 464.60M | 396.70M | 178.00M | 133.20M | 122.20M |
| Gross Profit | 456.20M | 391.80M | 176.30M | 131.20M | 119.90M |
| EBITDA | 461.70M | 468.30M | 161.70M | 116.20M | 110.20M |
| Net Income | 295.70M | 347.90M | 118.70M | 734.50M | 257.30M |
Balance Sheet | |||||
| Total Assets | 8.16B | 6.61B | 6.48B | 3.66B | 2.63B |
| Cash, Cash Equivalents and Short-Term Investments | 143.40M | 41.80M | 111.90M | 51.30M | 51.40M |
| Total Debt | 2.99B | 2.10B | 2.12B | 1.03B | 842.70M |
| Total Liabilities | 3.42B | 2.48B | 2.51B | 1.09B | 888.70M |
| Stockholders Equity | 4.71B | 4.09B | 3.94B | 2.56B | 1.73B |
Cash Flow | |||||
| Free Cash Flow | 236.30M | 284.00M | 117.30M | 54.20M | 60.50M |
| Operating Cash Flow | 260.30M | 316.90M | 123.10M | 105.20M | 86.10M |
| Investing Cash Flow | -328.50M | -7.90M | 195.70M | -377.10M | -53.00M |
| Financing Cash Flow | 130.40M | -339.70M | -249.90M | 271.80M | -63.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £4.28B | 9.08 | 7.73% | 5.85% | 15.13% | 29.40% | |
71 Outperform | £165.02M | 12.94 | 7.33% | 7.43% | -10.95% | -30.09% | |
70 Outperform | £4.42B | 14.52 | 6.29% | 6.67% | 17.12% | -23.84% | |
68 Neutral | £4.88B | 14.28 | 5.29% | 6.34% | 7.21% | -13.23% | |
67 Neutral | £224.75M | 7.60 | 9.81% | 6.64% | 8.12% | 163.48% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £364.13M | 14.32 | 7.51% | 5.15% | -5.46% | -27.41% |